Trial intelligence / Profile preview

RFCA in PMVT and Heart Failure

NCT07130175Completed

Start
Dec 2022
Primary completion
Dec 2024
Countries
1
01

Overview

Randomised, open-label trial in polymorphic ventricular tachycardia (PVT) and heart failure (HF) (2 arms). Primary endpoints: Left Ventricular Ejection Fraction at 6 months, Left Ventricular End-Diastolic Volume at 6 months and 2 more. Started Dec 2022; status: completed.

02

Conditions

polymorphic ventricular tachycardia (PVT)heart failure (HF)

Beyond the preview

Go deeper on NCT07130175.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07130175.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call